For the treatment of type 2 diabetes, empagliflozin should be ...

the preferred first line therapy (instead of metformin).
0% (0 votes)
the preferred first add-on therapy with metformin.
14% (5 votes)
a favorably considered add-on therapy.
62% (23 votes)
a third or fourth line therapy after more traditional options.
24% (9 votes)
Total votes: 37